Clinical Trials in Detroit

Showing 921-940 of 19,719 trials

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

NCT05066217

This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in children and adult participants with Lennox-Gastaut syndrome (LGS).

Lennox Gastaut Syndrome

Epygenix260 participantsStarted Apr 2025

Little Rock, Arkansas, United States • Orange, California, United States • Orange, California, United States +17 more locations

Active Not RecruitingPhase 3< 1 mile

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

NCT04464226

The aim of this study is to provide darolutamide treatment to patients who participated in a previous study with darolutamide supported by Bayer and the treating doctor considers that the continuation of the treatment with darolutamide to be beneficial. Patients will be carried over from the previous studies and continue in this study with darolutamide treatment on the same dosage. They will also return to the study centers for doctor's visits as often as they did in the previous study.

Cancer

Bayer402 participantsStarted Oct 2020

Homewood, Alabama, United States • Chandler, Arizona, United States • Los Angeles, California, United States +332 more locations

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

Find Trials by Condition in Detroit

Radioembolization Versus External Radiation Therapy

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers

Testing the Addition of an Anti-cancer Drug, SNDX-5613, to the Standard Chemotherapy Treatment (Daunorubicin and Cytarabine) for Newly Diagnosed Patients With Acute Myeloid Leukemia That Has Changes in NPM1 or MLL/KMT2A Gene

COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide

A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT

BEETroot Juice to Reverse Functional Impairment in PAD

Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Perform® Humeral System - Fracture Study (PFX)

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors